Kestra Private Wealth Services’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
Other funds holding BIIB
Kestra Private Wealth Services's BIIB Position: Q4 2024 in Review
Kestra Private Wealth Services sold out of Biogen (BIIB) in Q4 2024, closing a stake of 1,440 shares — an estimated $279K sold.
Kestra Private Wealth Services first reported a position in BIIB in Q3 2020 and held it in 13 quarters. The position peaked at $1.36M in Q4 2023. 876 funds tracked by Wall St. Rank hold BIIB as of Q4 2024.
- Kestra Private Wealth Services reported no remaining Biogen position as of Q4 2024 after selling out during the quarter.
- Kestra Private Wealth Services sold 1,440 Biogen shares in Q4 2024, an estimated $279K.
- Kestra Private Wealth Services first reported a position in Biogen in Q3 2020 and held it in 13 quarters.
- Kestra Private Wealth Services's Biogen position peaked at $1.36M in Q4 2023.
- 876 funds tracked by Wall St. Rank held Biogen as of Q4 2024.
Based on Kestra Private Wealth Services's 13F filing for Q4 2024, filed 28 Jan 2025.